Pharmacological treatment of abdominal aortic aneurysm (Q37489199)

20 August 2017

1 reference

title

Pharmacological treatment of abdominal aortic aneurysm (English)

1 reference

20 August 2017

1 reference

Takashi Miyake

1

1 reference

20 August 2017

Ryuichi Morishita

series ordinal

2

1 reference

20 August 2017

publication date

19 May 2009

1 reference

20 August 2017

published in

Cardiovascular Research

1 reference

20 August 2017

volume

83

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

436-443

1 reference

The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Management of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Natural history of patients with abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Is warfarin underused in the treatment of elderly persons with atrial fibrillation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

High prevalence of abdominal aortic aneurysm in a primary care screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Immediate repair compared with surveillance of small abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells--a potential mechanism for the weakening and rupture of atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Mast cells enhance T cell activation: Importance of mast cell-derived TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Size matters: the relationship between MMP-9 expression and aortic diameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Cysteine protease activity in the wall of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Elastogenesis in human arterial disease: a role for macrophages in disordered elastin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Simvastatin suppresses experimental aortic aneurysm expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Rapamycin suppresses experimental aortic aneurysm growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Transcription-factor mutations and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of nuclear factor kappaB and Ets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

NF-kappaB induced by IL-1beta inhibits elastin transcription and myofibroblast phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Ets-1 positively regulates Fas ligand transcription via cooperative interactions with Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Bcl-XL expression correlates with primary macrophage differentiation, activation of functional competence, and survival and results from synergistic transcriptional activation by Ets2 and PU.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

Ubiquitous Elevation of Matrix Metalloproteinase-2 Expression in the Vasculature of Patients With Abdominal Aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP155

21 January 2018

Identifiers

DOI

10.1093/CVR/CVP155

1 reference

20 August 2017

1 reference